Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
Maisons V, Duval A, Mesnard L, Frimat M, Fakhouri F, Grangé S, Servais A, Cartery C, Fauchier L, Coppo P, Titeca-Beauport D, Fage N, Delmas Y, Quérard AH, Seret G, Bobot M, Le Quintrec M, Ville S, von Tokarski F, Chauvet S, Wynckel A, Martins M, Schurder J, Barbet C, Sautenet B, Gatault P, Caillard S, Vuiblet V, Halimi JM; MATRIX Consortium Group. Maisons V, et al. Among authors: coppo p. Kidney Int. 2024 May;105(5):1100-1112. doi: 10.1016/j.kint.2024.02.014. Epub 2024 Feb 29. Kidney Int. 2024. PMID: 38431217
Cancer awareness in atypical thrombotic microangiopathies.
Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S, Schleinitz N, Valla D, Galicier L, Bengrine-Lefèvre L, Gorin NC, Coppo P; Reference Center for the Management of Thrombotic Microangiopathies. Oberic L, et al. Among authors: coppo p. Oncologist. 2009 Aug;14(8):769-79. doi: 10.1634/theoncologist.2009-0067. Epub 2009 Aug 14. Oncologist. 2009. PMID: 19684072 Free article.
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura.
Pavenski K, Scully M, Coppo P, Cataland S, Knöbl P, Peyvandi F, Kremer Hovinga JA, de la Rubia J, Khan U, Marques AP, Gunawardena S. Pavenski K, et al. Among authors: coppo p. Res Pract Thromb Haemost. 2024 Jul 15;8(5):102512. doi: 10.1016/j.rpth.2024.102512. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39221451 Free PMC article.
Splenectomy allows remission of angioedema with acquired C1-inhibitor deficiency associated with splenic marginal zone lymphoma.
Valayer S, Defendi F, El Sissy C, Roos-Weil D, Ackermann F, Bouillet L, Boccon-Gibod I, Coppo P, Chafai N, Kalmi G, McAvoy C, Fain O, Gobert D. Valayer S, et al. Among authors: coppo p. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2543-2546. doi: 10.1016/j.jaip.2024.05.047. Epub 2024 Jun 6. J Allergy Clin Immunol Pract. 2024. PMID: 38851485 No abstract available.
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes.
Jacobs JW, Stanek CG, Booth GS, Symeonidis A, Shih AW, Allen ES, Gavriilaki E, Grossman BJ, Pavenski K, Moorehead A, Peyvandi F, Agosti P, Mancini I, Stephens LD, Raval JS, Mingot-Castellano ME, Crowe EP, Daou L, Pai M, Arnold DM, Marques MB, Henrie R, Smith TW, Sreenivasan G, Siniard RC, Wallace LR, Yamada C, Duque MA, Wu Y, Harrington TJ, Byrnes DM, Bitsani A, Davis AK, Robinson DH, Eichbaum Q, Figueroa Villalba CA, Juskewitch JE, Kaiafa G, Kapsali E, Klapper E, Perez-Alvarez I, Klein MS, Kotsiou N, Lalayanni C, Mandala E, Aldarweesh F, Alkhateb R, Fortuny L, Mellios Z, Papalexandri A, Parsons MG, Schlueter AJ, Tormey CA, Wellard C, Wood EM, Jia S, Wheeler AP, Powers AA, Webb CB, Yates SG, Bouzid R, Coppo P, Bloch EM, Adkins BD. Jacobs JW, et al. Among authors: coppo p. Am J Hematol. 2024 Nov;99(11):2063-2074. doi: 10.1002/ajh.27458. Epub 2024 Aug 13. Am J Hematol. 2024. PMID: 39136282 Free article.
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.
Stocker N, Alsuliman T, Corre E, Ricard L, Kaoui F, Coppo P, Brissot E, Dulery R, Banet A, Van de Wyngaert Z, Legrand O, Bonnin A, Mohty M, Malard F, Marjanovic Z. Stocker N, et al. Among authors: coppo p. Clin Hematol Int. 2025 Jan 3;7(1):1-9. doi: 10.46989/001c.127828. eCollection 2025. Clin Hematol Int. 2025. PMID: 39764201 Free PMC article.
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT). Weisinger J, et al. Among authors: coppo p. Am J Hematol. 2025 Feb;100(2):350-353. doi: 10.1002/ajh.27550. Epub 2024 Dec 12. Am J Hematol. 2025. PMID: 39668454 Free PMC article. No abstract available.
[Management of congenital thrombotic thrombocytopenic purpura in the era of recombinant ADAMTS13 protein: Recommendations from the Reference Center for Thrombotic Microangiopathies (CNR-MAT)].
Joly BS, Joseph A, Dossier C, Kwon T, Gouge-Biebuyck N, Boyer O, Tsatsaris V, Veyradier A, Coppo P; Centre national de référence des microangiopathies thrombotiques (CNR-MAT); Société de néphrologie pédiatrique (SNP). Joly BS, et al. Among authors: coppo p. Rev Med Interne. 2024 Nov 21:S0248-8663(24)01277-3. doi: 10.1016/j.revmed.2024.11.004. Online ahead of print. Rev Med Interne. 2024. PMID: 39578196 Free article. Review. French.
318 results